04/10/2025
4:16 PM | Theravance Biopharma (Filer)
| Form DEF 14A | |
03/07/2025
5:15 AM | Theravance Biopharma (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/04/2025
5:17 PM | Theravance Biopharma (Issuer)
Winningham Rick E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
5:07 PM | Grimaud Brett A. (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
5:09 PM | Miller Aine (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
5:11 PM | Sawaf Aziz (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
5:05 PM | Farnum Rhonda (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/24/2025
6:24 PM | Farnum Rhonda (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/24/2025
6:26 PM | Grimaud Brett A. (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/24/2025
6:28 PM | Miller Aine (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/24/2025
6:30 PM | Sawaf Aziz (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for TBPH and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Theravance Biopharma and its competitors with MarketBeat's FREE daily newsletter. |
02/24/2025
6:32 PM | Theravance Biopharma (Issuer)
Winningham Rick E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2025
5:05 PM | Farnum Rhonda (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2024
5:04 PM | Farnum Rhonda (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2024
5:06 PM | Grimaud Brett A. (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2024
5:08 PM | Miller Aine (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2024
5:09 PM | Sawaf Aziz (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2024
5:10 PM | Theravance Biopharma (Issuer)
Winningham Rick E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/19/2024
8:08 PM | Theravance Biopharma (Issuer)
Winningham Rick E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/14/2024
8:53 AM | Madison Avenue Partners, LP (Filed by)
Theravance Biopharma (Subject)
| Form SC 13G/A | |
11/14/2024
5:06 AM | Theravance Biopharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/13/2024
7:42 PM | Farnum Rhonda (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/04/2024
2:33 PM | Theravance Biopharma (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
11/04/2024
1:10 PM | Theravance Biopharma (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
10/24/2024
3:44 PM | BlackRock, Inc. (Filed by)
Theravance Biopharma (Subject)
| Form SC 13G/A | |
09/23/2024
5:05 AM | Theravance Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/10/2024
5:02 AM | Theravance Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/09/2024
4:42 PM | BAUPOST GROUP LLC/MA (Filed by)
Theravance Biopharma (Subject)
| Form SC 13G/A | |
08/22/2024
7:03 PM | Farnum Rhonda (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/22/2024
7:05 PM | Grimaud Brett A. (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/22/2024
7:06 PM | Miller Aine (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/22/2024
7:07 PM | Sawaf Aziz (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/22/2024
7:09 PM | Theravance Biopharma (Issuer)
Winningham Rick E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/09/2024
5:02 PM | Samaha Eli (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/09/2024
5:05 PM | Theravance Biopharma (Issuer)
Winningham Rick E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/08/2024
3:57 PM | Theravance Biopharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/12/2024
5:15 PM | Farnum Rhonda (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2024
5:02 PM | Farnum Rhonda (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2024
5:04 PM | Grimaud Brett A. (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2024
5:06 PM | Miller Aine (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2024
5:08 PM | Sawaf Aziz (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
New “Trump” currency proposed in DC (Ad) According to one of the most connected men in Washington…
A surprising new bill was just introduced in Washington. Its purpose: to put Donald Trump’s face on the $100 note.
All to celebrate a new “golden age” for America.
 When you see what could happen – I think you’ll be excited. |
05/22/2024
5:10 PM | Theravance Biopharma (Issuer)
Winningham Rick E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2024
5:01 PM | Theravance Biopharma (Issuer)
Winningham Rick E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/15/2024
5:26 AM | Theravance Biopharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/10/2024
5:01 PM | Smaldone Alsup Laurie (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/10/2024
5:02 PM | BROSHY ERAN (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/10/2024
5:04 PM | Grant Jeremy T (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/10/2024
5:06 PM | GRAY SUSANNAH (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/10/2024
5:09 PM | MITCHELL DEAN J (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/10/2024
5:10 PM | O'Connor Donal (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/10/2024
5:12 PM | PAKIANATHAN DEEPIKA (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
